Business UpdateJun 23, 2026, 08:32 AM
TOMI SteraMist Adoption Grows Amid Rising Biosecurity Threats
AI Summary
TOMI Environmental Solutions announced continued growth in customer adoption and commercial demand for its SteraMist platform, driven by global organizations expanding preparedness efforts against emerging biological threats. The company has expanded deployments with healthcare providers and emergency response teams, both internationally and in the U.S., to strengthen environmental decontamination protocols. TOMI anticipates continued commercial momentum throughout 2026 and beyond, with future opportunities in automation and robotics to enhance large-scale decontamination capabilities.
Key Highlights
- TOMI reports continued growth in customer adoption and commercial demand for its SteraMist platform.
- Global organizations are expanding preparedness efforts against emerging biological threats.
- Recent outbreaks of Ebola, measles, and norovirus underscore the need for biosecurity.
- Expanded SteraMist deployments with healthcare providers and emergency response teams internationally.
- U.S. healthcare systems and federally supported programs are increasing SteraMist adoption.
- TOMI sees future opportunities in automation, robotics, and autonomous delivery systems.
- The global infection prevention market is expanding due to HAIs and pathogen risks.
Price Impact
More from TOMZ